PERRY SEXTON: Open Payments
NPI 1972665339 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 36 payments from 14 companies in 2025. Trend: 2023 $1,283 · 2024 $1,161 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 15 | $225 |
| ABBVIE INC. | 6 | $107 |
| Seqirus USA Inc | 2 | $45 |
| Novo Nordisk Inc | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Almatica Pharma LLC | 1 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Alkermes, Inc. | 1 | $28 |
| Boston Scientific Corporation | 1 | $26 |
| PFIZER INC. | 1 | $21 |
Products named: SUBLOCADE, VRAYLAR, Flucelvax, Rybelsus, QULIPTA, TRELEGY ELLIPTA, LOREEV XR, SPRAVATO.
Industry payments across CA — which companies pay providers there.
